Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
USPH 
US Physicalrapy Inc (USPH)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/14/2025: USPH (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
7 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $106.83
1 Year Target Price $106.83
| 2 | Strong Buy |
| 4 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -11.33% | Avg. Invested days 38 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 08/14/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.30B USD | Price to earnings Ratio 37.46 | 1Y Target Price 106.83 |
Price to earnings Ratio 37.46 | 1Y Target Price 106.83 | ||
Volume (30-day avg) 7 | Beta 1.45 | 52 Weeks Range 62.40 - 100.01 | Updated Date 08/15/2025 |
52 Weeks Range 62.40 - 100.01 | Updated Date 08/15/2025 | ||
Dividends yield (FY) 2.07% | Basic EPS (TTM) 2.29 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date 2025-08-06 | When - | Estimate 0.7 | Actual 0.81 |
Profitability
Profit Margin 5.28% | Operating Margin (TTM) 12.4% |
Management Effectiveness
Return on Assets (TTM) 4.24% | Return on Equity (TTM) 7.45% |
Valuation
Trailing PE 37.46 | Forward PE 36.63 | Enterprise Value 1578563151 | Price to Sales(TTM) 1.81 |
Enterprise Value 1578563151 | Price to Sales(TTM) 1.81 | ||
Enterprise Value to Revenue 2.16 | Enterprise Value to EBITDA 15.57 | Shares Outstanding 15204100 | Shares Floating 14883616 |
Shares Outstanding 15204100 | Shares Floating 14883616 | ||
Percent Insiders 1.98 | Percent Institutions 104.99 |
Upturn AI SWOT
US Physicalrapy Inc
Company Overview
History and Background
US Physical Therapy, Inc. was founded in 2003 and has grown through acquisitions and organic growth to become a major operator of outpatient physical therapy clinics.
Core Business Areas
- Outpatient Physical Therapy: Provides physical therapy services through owned and managed clinics. Services include pre- and post-operative care, rehabilitation for various injuries, and treatment for chronic conditions.
Leadership and Structure
The leadership team consists of key executives like the CEO, CFO, and COO. The organizational structure is hierarchical, with regional managers overseeing clinic operations.
Top Products and Market Share
Key Offerings
- Physical Therapy Services: Core physical therapy services cover a wide range of conditions. Market share data for individual services is not readily available, but USPh is a significant player in the fragmented outpatient physical therapy market. Competitors include ATI Physical Therapy, Select Medical, and local independent practices.
Market Dynamics
Industry Overview
The outpatient physical therapy market is growing due to an aging population, increasing prevalence of chronic conditions, and greater awareness of the benefits of physical therapy.
Positioning
US Physical Therapy, Inc. is a leading operator in the fragmented market, known for its strong acquisition strategy and efficient clinic management.
Total Addressable Market (TAM)
The TAM for outpatient physical therapy in the US is estimated to be tens of billions of dollars annually. USPh is positioned to capture a significant share through organic growth and acquisitions.
Upturn SWOT Analysis
Strengths
- Extensive clinic network
- Strong acquisition track record
- Experienced management team
- Decentralized operating model
Weaknesses
- Dependence on acquisitions for growth
- Exposure to reimbursement pressures
- Highly competitive market
- Integration risks from acquisitions
Opportunities
- Further acquisitions of smaller practices
- Expansion into new geographic markets
- Increased demand for physical therapy services
- Development of telehealth services
Threats
- Changes in healthcare regulations
- Reduced reimbursement rates from payers
- Increased competition from other providers
- Economic downturn affecting patient volumes
Competitors and Market Share
Key Competitors
- ATI Physical Therapy (No public symbol currently)
- Select Medical (SEM)
- Encompass Health (EHC)
Competitive Landscape
US Physical Therapy, Inc. competes on the basis of clinic locations, service quality, and relationships with physicians. Advantages include a decentralized operating model and strong acquisition track record. Disadvantages include integration risks and reimbursement pressures.
Major Acquisitions
Multiple clinic acquisitions, names vary year to year
- Year: 2023
- Acquisition Price (USD millions): 64.4
- Strategic Rationale: Expanding the clinic network and entering new geographic markets.
Growth Trajectory and Initiatives
Historical Growth: US Physical Therapy, Inc. has grown significantly through acquisitions and organic growth in recent years.
Future Projections: Analyst estimates project continued growth in revenue and earnings due to ongoing demand for physical therapy services and continued acquisitions.
Recent Initiatives: Recent initiatives include acquiring new clinic locations and implementing telehealth services.
Summary
US Physical Therapy, Inc. is a strong player in the fragmented outpatient physical therapy market. The company's growth strategy relies heavily on acquisitions. Reimbursement pressures and integration risks are key challenges. Continued organic growth and successful acquisitions will be critical for future success.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings (SEC)
- Industry reports
- Analyst estimates
Disclaimers:
This analysis is based on publicly available information and analyst estimates. It is not financial advice. Market share data is approximate.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About US Physicalrapy Inc
Exchange NYSE | Headquaters Houston, TX, United States | ||
IPO Launch date 1992-05-28 | CEO & Chairman Mr. Christopher J. Reading | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 4034 | Website https://www.usph.com |
Full time employees 4034 | Website https://www.usph.com | ||
U.S. Physical Therapy, Inc. operates and manages outpatient physical therapy clinics. The company operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. U.S. Physical Therapy, Inc. was founded in 1990 and is based in Houston, Texas.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.